Sample Page

Troponin C, fast skeletal muscle (sTnC) is a protein that in humans is encoded by the TNNC2 gene. It is the troponin C paralog expressed in fast-twitching fibers of skeletal muscle.[5][6]

Troponin (Tn), is a key protein complex in the regulation of striated muscle contraction, composed of three subunits. The TnI subunit inhibits actomyosin ATPase, the TnT subunit binds tropomyosin and TnC, while the TnC subunit binds calcium and overcomes the inhibitory action of the troponin complex on actin thin filaments. The protein encoded by the TNNC2 gene is the TnC subunit.[6]

There are already multiple troponin activators that bind to fast skeletal troponin C (TNNC2), of which tirasemtiv[7] has been tested in multiple clinical trials.[8][9][10]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000101470Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000017300Ensembl, May 2017
  3. ^ “Human PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ “Mouse PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Gahlmann R, Kedes L (Aug 1990). “Cloning, structural analysis, and expression of the human fast twitch skeletal muscle troponin C gene”. J Biol Chem. 265 (21): 12520–8. doi:10.1016/S0021-9258(19)38376-0. PMID 2373703.
  6. ^ a b “Entrez Gene: TNNC2 troponin C type 2 (fast)”.
  7. ^ Russell AJ, Hartman JJ, Hinken AC, Muci AR, Kawas R, Driscoll L, Godinez G, Lee KH, Marquez D, Browne WF, Chen MM, Clarke D, Collibee SE, Garard M, Hansen R, Jia Z, Lu PP, Rodriguez H, Saikali KG, Schaletzky J, Vijayakumar V, Albertus DL, Claflin DR, Morgans DJ, Morgan BP, Malik FI (Mar 2012). “Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases”. Nature Medicine. 18 (3): 452–455. doi:10.1038/nm.2618. PMC 3296825. PMID 22344294.
  8. ^ Shefner JM, Wolff AA, Meng L (Dec 2013). “The relationship between tirasemtiv serum concentration and functional outcomes in patients with ALS”. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14 (7–8): 582–5. doi:10.3109/21678421.2013.817587. PMID 23952600. S2CID 25563161.
  9. ^ Bauer TA, Wolff AA, Hirsch AT, Meng LL, Rogers K, Malik FI, Hiatt WR (May 2014). “Effect of tirasemtiv, a selective activator of the fast skeletal muscle troponin complex, in patients with peripheral artery disease”. Vascular Medicine. 19 (4): 297–306. doi:10.1177/1358863X14534516. PMID 24872402. S2CID 25185883.
  10. ^ Sanders DB, Rosenfeld J, Dimachkie MM, Meng L, Malik FI, Andrews J, Barohn R, Corse A, Deboo A, Felice K, Harati Y, Heiman-Patterson T, Howard JF, Jackson C, Juel V, Katz J, Lee J, Massey J, McVey A, Mozaffar T, Pasnoor M, Small G, So Y, Wang AK, Weinberg D, Wolff AA (Apr 2015). “A double-blinded, randomized, placebo-controlled trial to evaluate efficacy, safety, and tolerability of single doses of tirasemtiv in patients with acetylcholine receptor-binding antibody-positive myasthenia gravis”. Neurotherapeutics. 12 (2): 455–60. doi:10.1007/s13311-015-0345-y. PMC 4404445. PMID 25742919.

Further reading